Yearly Publication Trends - immunotherapy

Year	Publication Count
2024	7328
2023	20272
2022	11576
2021	8900
2020	6275
2019	3694
2018	2596
2017	2338
2016	2377
2015	1506
2014	1485

Relevant Publications

A Guideline Strategy for Identifying Genes/Proteins Regulating Antiviral Innate Immunity.

Issue Release: 2025

Exploring cellular diversity in lung adenocarcinoma epithelium: Advancing prognostic methods and immunotherapeutic strategies.

Issue Release: 2024

Current status of anaplastic thyroid carcinoma.

Issue Release: 2024

Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.

Issue Release: 2024

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

Issue Release: 2024

An overview of the contemporary diagnosis and management approaches for anaplastic thyroid carcinoma.

Issue Release: 2024

An anoikis-related gene signature predicts prognosis, drug sensitivity, and immune microenvironment in cholangiocarcinoma.

Issue Release: 2024

Neoadjuvant Immunotherapy Effectiveness in Patients With Microsatellite Instability-High (MSI-H) Gastric Cancer.

Issue Release: 2024

Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer.

Issue Release: 2024

A machine learning radiomics based on enhanced computed tomography to predict neoadjuvant immunotherapy for resectable esophageal squamous cell carcinoma.

Issue Release: 2024

Organoids in gastrointestinal diseases: from bench to clinic.

Issue Release: 2024

Microbiome-driven anticancer therapy: A step forward from natural products.

Issue Release: 2024

piSTING: A Pocket-Independent Agonist Based on Multivalency-Driven STING Oligomerization.

Issue Release: 2024

HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis.

Issue Release: 2024

The immune microenvironment of lung adenocarcinoma featured with ground-glass nodules.

Issue Release: 2024

Light-Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy.

Issue Release: 2024

Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker.

Issue Release: 2024

Mapping the landscape: a bibliometric study of global chimeric antigen receptor T cell immunotherapy research.

Issue Release: 2024

Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures.

Issue Release: 2024

Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment.

Issue Release: 2024

What are the Applications of Tracking Technologies in Nanotechnology?

What is her role at Rice University?

What Are Dual-Use Technologies?

How Will Nanotechnology Influence Manufacturing?

What are Characterization Facilities?

Why are Spring Dampers Important in Nanotechnology?

How can researchers get involved with ACS in the field of Nanotechnology?

How Can Surfactants Help in Solution Mixing?

How does Figshare Benefit Nanotechnology Researchers?

What Are Some Examples of NGOs Involved in Nanotechnology?

Partnered Content Networks

Relevant Topics